<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Large volume (therapeutic) thoracentesis: Procedure and complications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Large volume (therapeutic) thoracentesis: Procedure and complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Large volume (therapeutic) thoracentesis: Procedure and complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John T Huggins, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Amit Chopra, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">V Courtney Broaddus, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 09, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H25574975"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Large volume thoracentesis refers to the removal of more than one liter of pleural fluid during a therapeutic thoracentesis. Although this definition is somewhat arbitrary, we define it as such for the purposes of this topic.  </p><p>The technique for large volume thoracentesis will be reviewed here. The diagnostic evaluation of pleural fluid and the techniques for pleural manometry and diagnostic thoracentesis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16859.html" rel="external">"Measurement and interpretation of pleural pressure (manometry): Indications and technique"</a> and  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis"</a> and  <a class="medical medical_review" href="/z/d/html/6698.html" rel="external">"Pleural fluid analysis in adults with a pleural effusion"</a> and  <a class="medical medical_review" href="/z/d/html/6707.html" rel="external">"Diagnostic evaluation of the hemodynamically stable adult with a pleural effusion"</a>.)</p><p class="headingAnchor" id="H25575598"><span class="h1">INDICATIONS AND CONTRAINDICATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Indications – The indication for large volume thoracentesis is dyspnea due to a moderate to large pleural effusion confirmed by physical examination and chest radiography. One study of 145 patients who underwent therapeutic thoracentesis reported improved symptoms and exercise tolerance in most patients with minimal changes in lung spirometry or oxygenation [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1">The exceptions to this rule include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hepatic hydrothorax – Transudative pleural effusions due to liver failure are not generally managed with large volume thoracentesis, although it may occasionally be necessary for relief of severe dyspnea or hypoxemia due to the effusion. This is because pleural fluid tends to reaccumulate rapidly following thoracentesis and serial thoracenteses are associated with increased complication rates in this setting [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/1242.html" rel="external">"Hepatic hydrothorax", section on 'Management'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unexpandable lung – If unexpandable lung is suspected or confirmed, large volume thoracentesis is unlikely to be successful and may increase the risk of complications. (See  <a class="medical medical_review" href="/z/d/html/6697.html" rel="external">"Diagnosis and management of pleural causes of nonexpandable lung"</a> and  <a class="medical medical_review" href="/z/d/html/16859.html" rel="external">"Measurement and interpretation of pleural pressure (manometry): Indications and technique", section on 'Interpretation of pleural pressures'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Contraindications – General contraindications of thoracentesis (eg, severe coagulopathy) which also apply to patients undergoing large volume thoracentesis, are provided separately. (See  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Indications and contraindications'</a>.)</p><p></p><p class="headingAnchor" id="H25575605"><span class="h1">PROCEDURE</span></p><p class="headingAnchor" id="H291949970"><span class="h2">Equipment and technique</span><span class="headingEndMark"> — </span>The equipment for thoracentesis and also pleural manometry should be available:</p><p class="bulletIndent1"><span class="glyph">●</span>Thoracentesis – The equipment (<a class="graphic graphic_table graphicRef83425" href="/z/d/graphic/83425.html" rel="external">table 1</a>), preparation, and technique for large volume thoracentesis is identical to that described for diagnostic thoracentesis, the details of which are provided separately. (See  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Equipment'</a> and  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Technique'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Manometry – For most patients in whom large volume thoracentesis is planned, and in particular for those with suspected unexpandable lung (ie, trapped lung or lung entrapment), we perform manometry during the procedure based upon the rationale that it can guide the operator in deciding how much fluid may be removed. However, the expertise for pleural manometry is not always available. The equipment and technique for pleural manometry is also provided separately. (See  <a class="medical medical_review" href="/z/d/html/16859.html" rel="external">"Measurement and interpretation of pleural pressure (manometry): Indications and technique", section on 'Technique'</a>.)</p><p></p><p class="headingAnchor" id="H25575612"><span class="h2">Determining the volume of fluid to be removed</span><span class="headingEndMark"> — </span>When large volume thoracentesis is planned, we monitor symptoms and in those with suspected unexpandable lung (ie, trapped lung or lung entrapment), we additionally use pleural manometry to guide the volume of fluid removal (<a class="graphic graphic_picture graphicRef116952" href="/z/d/graphic/116952.html" rel="external">picture 1</a>). Fluid removal should be stopped if the patient develops intractable chest pain or becomes hypotensive or if no more fluid can be aspirated [<a href="#rid3">3-8</a>]. When manometry is being used, thoracentesis may also be discontinued if the pleural pressure decreases by no more than 10 cm H<sub>2</sub>O between two measurement to a value less than or equal to -10 cm H<sub>2</sub>O (relative to the position of the left atrium). If a patient experiences persistent anterior vague chest discomfort and manometry is not being used, some experts introduce ambient air or sterile <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> (eg, 10 to 20 mL aliquots) into the pleural space until discomfort is relieved. This usually relieves the discomfort immediately when negative pressure is the cause of pain.</p><p>There is no single absolute maximum volume of fluid that can be safely removed during therapeutic thoracentesis. Traditionally, fluid removal was discontinued when the total amount of fluid removed reached 1000 to 1500 mL [<a href="#rid8">8</a>]. However, this practice does not always prevent adverse effects and, in fact, many patients do well with removal of more than 1500 mL. In addition, although patients undergoing large volume thoracentesis are at higher risk of re-expansion pulmonary edema (RPE) and procedure-related pneumothorax, these complications do not clearly correlate with the volume of fluid removed [<a href="#rid9">9,10</a>]. </p><p>The onset of vague chest discomfort generally correlates with development of more negative pleural pressures, which in turn indicates that additional fluid removal may be harmful. In a series of 169 patients, the onset of chest discomfort was associated with lower (more negative) pleural pressures and a greater total change in pleural pressure, while cough did not correlate with lower pressures or the change in pressure [<a href="#rid6">6</a>]. Among those who developed chest discomfort, the majority had pleural pressure more positive than -20 cm H<sub>2</sub>O (ie, pressures above which additional removal of fluid is likely safe) and only 22 percent had a potentially unsafe decrease in pleural pressure (ie, more negative than -20 cm H<sub>2</sub>O), suggesting that stopping fluid removal at the onset of chest discomfort avoids “unsafe” pleural pressures in the majority. </p><p>However, relying on symptoms is not fool-proof since some patients may be asymptomatic despite excessively negative pleural pressures and use does not always protect against the development of complications including pneumothorax ex vacuo and re-expansion pulmonary edema (REPE). As an example, one trial of 128 patients with free-flowing effusions estimated to be at least 0.5 L were randomized to symptom-guided or manometry-guided fluid removal [<a href="#rid11">11</a>]. In both groups drainage was discontinued early if patients developed persistent chest discomfort, intractable cough, or other complications, and additionally, in the manometry group, if end-expiratory pleural pressure was lower than -20 cm H<sub>2</sub>O or declined by more than 10 cm H<sub>2</sub>O between two measurements to a value less than or equal to -10 cm H<sub>2</sub>O. Similar symptoms of chest discomfort was reported in both groups at the end of thoracentesis. However, six patients in the control group developed pneumothorax ex vacuo (ie, a sign of unexpandable lung) compared with zero in the patients who underwent manometry. These results further support the value of manometry in detecting unexpandable lung, especially when large volumes of pleural fluid are being removed. Similarly, in a series of 185 large volume thoracenteses, pleural fluid pressure was monitored and fluid removal stopped at the onset of intractable chest discomfort or a pleural pressure of less than -20 cm H<sub>2</sub>O [<a href="#rid12">12</a>]. The mean amount of fluid removed was 1670 mL and the range 1000 to 6550 mL. Only one patient developed significant REPE. (See <a class="local">'Complications'</a> below.)</p><p class="headingAnchor" id="H25575626"><span class="h2">Assessment after fluid removal</span></p><p class="headingAnchor" id="H1633291740"><span class="h3">Clinical assessment</span><span class="headingEndMark"> — </span>Following large volume thoracentesis, all patients should be clinically assessed for improvement in dyspnea and the response documented since this may impact future decisions regarding removal of additional fluid or placement of a chest tube thoracostomy or tunneled catheter. If symptoms improve with removal of fluid (especially in the setting of unexpandable lung) then most experts consider that patients are likely to respond to the additional removal or drainage of any remaining pleural fluid. </p><p class="headingAnchor" id="H2730713780"><span class="h3">Imaging</span><span class="headingEndMark"> — </span>Similar to patients undergoing diagnostic thoracentesis, post-procedural imaging, usually ultrasound, is performed to assess for a pneumothorax and the amount of residual pleural fluid. The details of this imaging are provided separately. (See  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Follow-up'</a>.)</p><p>For patients with a pleural pressure at the end of thoracentesis that is more negative than -20 cm H<sub>2</sub>O or with an abnormally high elastance (&gt;14.5 cm H<sub>2</sub>O/L; ie, trapped lung), in whom prior chest computed tomography (CT) does not readily identify a visceral pleural rind to suggest trapped lung, an air contrast CT scan of the chest is sometimes obtained to verify the presence of visceral pleural thickening as a cause of trapped lung physiology. The technique of air contrast CT of the pleura is described separately. (See  <a class="medical medical_review" href="/z/d/html/6697.html" rel="external">"Diagnosis and management of pleural causes of nonexpandable lung", section on 'Imaging'</a>.) </p><p class="headingAnchor" id="H25578795"><span class="h3">Effect on pulmonary function</span><span class="headingEndMark"> — </span>Pulmonary function tests (PFTs) are <strong>not</strong> routinely performed after large volume thoracentesis. This is based upon the rationale that, although pulmonary function improves, the degree of improvement does not correlate well with the volume of fluid withdrawn and management is not impacted by the information gained on PFTs [<a href="#rid13">13-15</a>]. In a series of 26 thoracenteses, the improvement in the forced vital capacity (FVC) was small relative to the amount of fluid withdrawn [<a href="#rid13">13</a>]; the mean vital capacity improved 410 +/- 390 mL in patients who had 1740 +/- 900 mL of fluid removed. After the removal of 800 mL of pleural fluid, patients with higher (ie, less negative) pleural pressures and those with smaller decreases in the pleural pressure had greater improvements in their pulmonary function after thoracentesis, likely indicating expandable lung and implying that patients with more negative pleural pressure had unexpandable lung limiting the benefit of fluid removal. A study from Australia, examined 145 patients who underwent thoracentesis for breathlessness associated with the pleural effusion. There was only a small change noticed in spirometry findings and no change in oxygenation after thoracentesis. Abnormal diaphragm shape and movement were significantly associated with relief of breathlessness after thoracentesis [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults", section on 'Lung volumes'</a> and  <a class="medical medical_review" href="/z/d/html/16859.html" rel="external">"Measurement and interpretation of pleural pressure (manometry): Indications and technique", section on 'Interpretation of pleural pressures'</a>.)</p><p class="headingAnchor" id="H25575633"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>The complications associated with large volume thoracentesis are similar to those associated with diagnostic thoracentesis (eg, pneumothorax, bleeding, infection), which are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Complications'</a>.). </p><p>Although the risk of complications correlates imperfectly with the volume of fluid removed, the risk of re-expansion pulmonary edema (RPE) and pneumothorax are thought to be higher in those undergoing large volume thoracentesis than in those undergoing diagnostic thoracentesis or &lt;1 L thoracentesis.   </p><p class="headingAnchor" id="H25578838"><span class="h2">Re-expansion pulmonary edema</span><span class="headingEndMark"> — </span>Symptomatic RPE is an uncommon complication of large volume thoracentesis, occurring in less than 1 percent of procedures [<a href="#rid12">12,16-19</a>], while asymptomatic radiographic evidence of pulmonary edema (eg, usually on the side of the thoracentesis but occasionally bilateral) is slightly more common (&lt;2 percent) [<a href="#rid8">8,20</a>]. Rarely, REPE occurs with drainage of smaller volumes of fluid [<a href="#rid21">21-23</a>]. As an example, one study showed that although REPE was very rare during large volume thoracentesis (0.01 percent of cases), for every 1 mL of fluid removed there was a 0.18 percent increase in the risk of REPE [<a href="#rid24">24</a>]. Poor performance status may increase the risk [<a href="#rid19">19</a>]. The clinical presentation, diagnosis, and management of REPE are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3456.html" rel="external">"Noncardiogenic pulmonary edema", section on 'Re-expansion pulmonary edema'</a>.) </p><p class="headingAnchor" id="H25578845"><span class="h2">Pneumothorax (including pneumothorax ex vacuo)</span><span class="headingEndMark"> — </span>The risk of post-procedure pneumothorax (from iatrogenic lung puncture, inadvertent introduction of air during the procedure, and pneumothorax ex vacuo) increases with the volume of fluid withdrawn, although some patients appear to tolerate larger volumes of fluid removal than others [<a href="#rid7">7,8,19,25</a>]. In a prospective study of 735 thoracenteses in 471 patients, compared with drainage of 0.8 to 1.2 L, drainage of 1.8 to 2.2 L was associated with a more than threefold increase in risk for pneumothorax and, after drainage of 2.3 L or more, the increase in risk was almost six-fold [<a href="#rid25">25</a>]. In another retrospective study, pneumothorax developed in 4 percent of patients in whom ≥1.5 L was removed, but only 0.3 percent required intervention [<a href="#rid19">19</a>]. </p><p>While most pneumothoraces are iatrogenic in nature due to lung puncture or the introduction of air into the pleural space, some are indicative of underlying unexpandable lung (ie, pneumothorax ex vacuo). Pneumothorax ex vacuo refers to the development of a pneumothorax (<a class="graphic graphic_diagnosticimage graphicRef90376" href="/z/d/graphic/90376.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef90386" href="/z/d/graphic/90386.html" rel="external">image 2</a> and <a class="graphic graphic_diagnosticimage graphicRef70959" href="/z/d/graphic/70959.html" rel="external">image 3</a>) due to strongly negative pleural pressure created during pleural fluid removal. The air may enter the pleural space across the visceral pleura of the lung without creation of a lung puncture [<a href="#rid7">7,26</a>]. The causes of pneumothorax ex vacuo are attributed to an unexpandable lung (eg, from chronic atelectasis, endobronchial obstruction, and visceral pleural restriction due to either a trapped lung or lung entrapment by an inflammatory or malignant process), details of which are provided separately. (See  <a class="medical medical_review" href="/z/d/html/6697.html" rel="external">"Diagnosis and management of pleural causes of nonexpandable lung"</a>.)</p><p>Of note, postprocedure radiographs of a pneumothorax ex vacuo may show ipsilateral volume loss (rather than an unchanged or increased volume of the hemithorax), and the pneumothorax may be located at the base of the lung in the area where pleural fluid was withdrawn. </p><p>Post-procedure pneumothorax is managed in a similar fashion to spontaneous pneumothorax, with the exception that no intervention is required for pneumothorax ex vacuo. (See  <a class="medical medical_review" href="/z/d/html/6691.html" rel="external">"Treatment of secondary spontaneous pneumothorax in adults", section on 'Other pneumothorax types'</a>.)</p><p class="headingAnchor" id="H3358448590"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112226.html" rel="external">"Society guideline links: Pleural effusion"</a>.)</p><p class="headingAnchor" id="H25576154"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Large volume thoracentesis is a therapeutic procedure that removes 1 liter or more of pleural fluid. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The indication for large volume thoracentesis is dyspnea due to a moderate to large pleural effusion confirmed by physical examination and chest radiography. Transudative pleural effusions due to liver failure and effusions associated with unexpandable lung are not typically managed with large volume thoracentesis. (See <a class="local">'Introduction'</a> above and <a class="local">'Indications and contraindications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The equipment (<a class="graphic graphic_table graphicRef83425" href="/z/d/graphic/83425.html" rel="external">table 1</a>), preparation, and technique for large volume thoracentesis is similar to that described for diagnostic thoracentesis. For most patients, and in particular for those with known or suspected unexpandable lung (ie, trapped lung or lung entrapment), we prefer that pleural manometry be performed during large volume thoracentesis based upon the rationale that it can guide the operator in deciding on the volume of fluid to be removed. (See <a class="local">'Procedure'</a> above and  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Equipment'</a> and  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Technique'</a> and  <a class="medical medical_review" href="/z/d/html/16859.html" rel="external">"Measurement and interpretation of pleural pressure (manometry): Indications and technique"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fluid removal should be discontinued when the patient develops intractable chest discomfort or when no more fluid can be aspirated, and, if pleural manometry is available, when the pleural pressure is more negative than -20 cm H<sub>2</sub>O, declines by more than 10 cm H<sub>2</sub>O between two measurements to a value less than or equal to -10 cm H<sub>2</sub>O, or the pleural elastance is greater than 14.5 cm H<sub>2</sub>O/L. Following large volume thoracentesis, all patients should be clinically assessed for improvement in dyspnea and imaged with ultrasound for residual fluid and pneumothorax. (See <a class="local">'Procedure'</a> above and  <a class="medical medical_review" href="/z/d/html/16859.html" rel="external">"Measurement and interpretation of pleural pressure (manometry): Indications and technique"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The complications associated with large volume thoracentesis are similar to those associated with diagnostic thoracentesis (eg, pneumothorax, bleeding, infection). Although the risk of complications correlates imperfectly with the volume of fluid removed, re-expansion pulmonary edema (REPE) and pneumothorax occur at higher rates in those undergoing large volume thoracentesis compared with patients undergoing diagnostic thoracentesis or when volumes &lt;1 L are removed. (see <a class="local">'Complications'</a> above and  <a class="medical medical_review" href="/z/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/3456.html" rel="external">"Noncardiogenic pulmonary edema", section on 'Re-expansion pulmonary edema'</a>). </p><p></p><p class="headingAnchor" id="H458464871"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Peter Doelken, MD, FCCP, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Muruganandan S, Azzopardi M, Thomas R, et al. The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion. Eur Respir J 2020; 55.</a></li><li><a class="nounderline abstract_t">Shojaee S, Khalid M, Kallingal G, et al. Repeat Thoracentesis in Hepatic Hydrothorax and Non-Hepatic Hydrothorax Effusions: A Case-Control Study. Respiration 2018; 96:330.</a></li><li><a class="nounderline abstract_t">Doelken P, Huggins JT, Pastis NJ, Sahn SA. Pleural manometry: technique and clinical implications. Chest 2004; 126:1764.</a></li><li><a class="nounderline abstract_t">Light RW, Jenkinson SG, Minh VD, George RB. Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis. Am Rev Respir Dis 1980; 121:799.</a></li><li><a class="nounderline abstract_t">Feller-Kopman D. Therapeutic thoracentesis: the role of ultrasound and pleural manometry. Curr Opin Pulm Med 2007; 13:312.</a></li><li><a class="nounderline abstract_t">Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracentesis. Chest 2006; 129:1556.</a></li><li><a class="nounderline abstract_t">Heidecker J, Huggins JT, Sahn SA, Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 2006; 130:1173.</a></li><li><a class="nounderline abstract_t">Havelock T, Teoh R, Laws D, et al. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii61.</a></li><li><a class="nounderline abstract_t">Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med 2010; 170:332.</a></li><li><a class="nounderline abstract_t">Daniels CE, Ryu JH. Improving the safety of thoracentesis. Curr Opin Pulm Med 2011; 17:232.</a></li><li><a class="nounderline abstract_t">Lentz RJ, Lerner AD, Pannu JK, et al. Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial. Lancet Respir Med 2019; 7:447.</a></li><li><a class="nounderline abstract_t">Feller-Kopman D, Berkowitz D, Boiselle P, Ernst A. Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Ann Thorac Surg 2007; 84:1656.</a></li><li><a class="nounderline abstract_t">Light RW, Stansbury DW, Brown SE. The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am Rev Respir Dis 1986; 133:658.</a></li><li><a class="nounderline abstract_t">Michaelides SA, Bablekos GD, Analitis A, et al. Temporal evolution of thoracocentesis-induced changes in spirometry and respiratory muscle pressures. Postgrad Med J 2017; 93:460.</a></li><li><a class="nounderline abstract_t">Cartaxo AM, Vargas FS, Salge JM, et al. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. Chest 2011; 139:1424.</a></li><li><a class="nounderline abstract_t">Mynarek G, Brabrand K, Jakobsen JA, Kolbenstvedt A. Complications following ultrasound-guided thoracocentesis. Acta Radiol 2004; 45:519.</a></li><li><a class="nounderline abstract_t">Jones PW, Moyers JP, Rogers JT, et al. Ultrasound-guided thoracentesis: is it a safer method? Chest 2003; 123:418.</a></li><li><a class="nounderline abstract_t">Lin YJ, Yu YH. Reexpansion pulmonary edema after large-volume thoracentesis. Ann Thorac Surg 2011; 92:1550.</a></li><li><a class="nounderline abstract_t">Sagar AES, Landaeta MF, Adrianza AM, et al. Complications following symptom-limited thoracentesis using suction. Eur Respir J 2020; 56.</a></li><li><a class="nounderline abstract_t">Tarver RD, Broderick LS, Conces DJ Jr. Reexpansion pulmonary edema. J Thorac Imaging 1996; 11:198.</a></li><li><a class="nounderline abstract_t">Kim JJ, Kim YH, Choi SY, et al. Contralateral reexpansion pulmonary edema with ipsilateral collapsed lung after pleural effusion drainage: a case report. J Cardiothorac Surg 2015; 10:68.</a></li><li><a class="nounderline abstract_t">Walter JM, Matthay MA, Gillespie CT, Corbridge T. Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema. Ann Am Thorac Soc 2016; 13:438.</a></li><li><a class="nounderline abstract_t">de Wolf SP, Deunk J, Cornet AD, Elbers PW. Case Report: Bilateral reexpansion pulmonary edema following treatment of a unilateral hemothorax. F1000Res 2014; 3:318.</a></li><li><a class="nounderline abstract_t">Ault MJ, Rosen BT, Scher J, et al. Thoracentesis outcomes: a 12-year experience. Thorax 2015; 70:127.</a></li><li><a class="nounderline abstract_t">Josephson T, Nordenskjold CA, Larsson J, et al. Amount drained at ultrasound-guided thoracentesis and risk of pneumothorax. Acta Radiol 2009; 50:42.</a></li><li><a class="nounderline abstract_t">Woodring JH, Baker MD, Stark P. Pneumothorax ex vacuo. Chest 1996; 110:1102.</a></li></ol></div><div id="topicVersionRevision">Topic 17172 Version 19.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32079642" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29991046" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Repeat Thoracentesis in Hepatic Hydrothorax and Non-Hepatic Hydrothorax Effusions: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15596671" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pleural manometry: technique and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7406313" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17534178" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Therapeutic thoracentesis: the role of ultrasound and pleural manometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16778274" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The relationship of pleural pressure to symptom development during therapeutic thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17035453" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pathophysiology of pneumothorax following ultrasound-guided thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20696688" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20177035" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pneumothorax following thoracentesis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21346571" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Improving the safety of thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30772283" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17954079" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Large-volume thoracentesis and the risk of reexpansion pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3963629" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28057838" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Temporal evolution of thoracocentesis-induced changes in spirometry and respiratory muscle pressures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21051387" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15515513" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Complications following ultrasound-guided thoracocentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576360" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Ultrasound-guided thoracentesis: is it a safer method?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21958824" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Reexpansion pulmonary edema after large-volume thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32499336" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Complications following symptom-limited thoracentesis using suction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8784733" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Reexpansion pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25952365" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Contralateral reexpansion pulmonary edema with ipsilateral collapsed lung after pleural effusion drainage: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26963356" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25713699" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Case Report: Bilateral reexpansion pulmonary edema following treatment of a unilateral hemothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25378543" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Thoracentesis outcomes: a 12-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19052935" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Amount drained at ultrasound-guided thoracentesis and risk of pneumothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8874276" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Pneumothorax ex vacuo.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
